Performance characteristics of a novel reusable intermediate-volume low-pressure cuffed endotracheal tube

1994 ◽  
Vol 38 (4) ◽  
pp. 363-367 ◽  
Author(s):  
J. HÄHNEL ◽  
H. TREIBER ◽  
F. KONRAD ◽  
T. MUTZBAUER ◽  
P. STEFFEN ◽  
...  
Anaesthesia ◽  
1976 ◽  
Vol 31 (4) ◽  
pp. 504-507 ◽  
Author(s):  
T. L. BRADBEER ◽  
M. L. JAMES ◽  
J. W. SEAR ◽  
J. F. SEARLE ◽  
R. Stacey

2013 ◽  
Vol 2013 ◽  
pp. 1-6 ◽  
Author(s):  
John Schweiger ◽  
Rachel Karlnoski ◽  
Devanand Mangar ◽  
Jaya Kolla ◽  
Gerardo Munoz ◽  
...  

Background. Ventilator-associated pneumonia (VAP) is a leading cause of morbidity and mortality in intensive care unit (ICU) patients, encompassing up to 15% of all hospital acquired infections. Our hospital implemented a facility-wide conversion from a low-volume high-pressure polyvinyl cuffed endotracheal tube (PV-cuffed ETT) to a high-volume low-pressure (HVLP) polyurethane-cuffed endotracheal tube (PU-cuffed ETT) in an effort to reduce the incidence of VAP. Methods. We completed an IRB approved, retrospective chart review comparing the number of episodes of VAP 12 months preceding and following the introduction of a new ETT. A diagnosis of VAP was made based upon the guidelines of our institution, consistent with the Center of Disease Control and Prevention definition. Results. The number of patients developing VAP the year after the ETT conversion reduced to 32 (16.3%) from 68 (24.7%) the year before the conversion (). The rate of VAP was reduced by 56% per ventilator day after the implementation of the PU-cuffed ETT (). No significant differences were observed in length of hospital stay, length of mechanical ventilation, or mortality before or after the conversion. Conclusions. We found that HVLP PU-cuffed ETTs were associated with a statistically significant reduction of VAP in the adult ICUs.


2019 ◽  
Vol 85 (8) ◽  
Author(s):  
Joan D. Marti ◽  
Gianluigi Li Bassi ◽  
Valentina Isetta ◽  
Miguel R. Lazaro ◽  
Eli Aguilera-Xiol ◽  
...  

2017 ◽  
Vol 27 (5) ◽  
pp. 494-500 ◽  
Author(s):  
Senthil G. Krishna ◽  
Mumin Hakim ◽  
Roby Sebastian ◽  
Heather L. Dellinger ◽  
Dmitry Tumin ◽  
...  

1985 ◽  
Vol 59 (4) ◽  
pp. 1222-1227 ◽  
Author(s):  
H. V. Forster ◽  
L. G. Pan ◽  
C. Flynn ◽  
G. E. Bisgard ◽  
R. E. Hoffer

We determined whether the [CO2] in the upper airways (UA) can influence breathing in ponies and whether UA [CO2] contributes to the attenuation of a thermal tachypnea during periods of elevated inspired CO2. Six ponies were studied 1 mo after chronic tracheostomies were created. For one protocol the ponies were breathing room air through a cuffed endotracheal tube. Another smaller tube was placed in the tracheostomy and directed up the airway. By use of this tube, a pump, and prepared gas mixtures, UA [CO2] was altered without affecting alveolar or arterial PCO2. When the ponies were at a neutral environmental temperature (TA) and breathing frequency (f) was 8 breaths X min-1, increasing UA [CO2] up to 18–20% had no effect on f. However, when TA was increased 20 degrees C to increase f to 50 breaths X min-1, then increasing UA [CO2] to 6% or to 18–20% reduced f by 5 +/- 1.7 (SE) and 12 +/- 1.6 breaths X min-1, respectively (t = 3.3, P less than 0.01). These data suggest that in the pony there exists a UA CO2-H+ sensory mechanism. For a second protocol the ponies were breathing a 6% CO2 gas mixture for 15 min in the normal fashion over the entire airway (nares breathing, NBr) or they were breathing this gas mixture for 15 min through the cuffed endotracheal tube (TBr). At a neutral TA, increasing inspired [CO2] to 6% resulted in a 6-breaths X min-1 increase in f during both NBr and TBr.


Sign in / Sign up

Export Citation Format

Share Document